The functional role of HEY1-NCOA2 was further explored using the histone deacetylase (HDAC) inhibitor panobinostat, which inhibited HEY1-NCOA2-associated gene expression (Sox9, Runx1, Hes1) and tumor growth in xenograft models. This evidence concerns the gene SOX9 and neoplasm.